search
Read and share opinions on AMGN (Amgen Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.
clarify Drug Manufacturers - General
bookmark Healthcare
public United States
Jan 13, 2026
$AMGN Like your favorite movie sequel, it’s got a solid following, but can it keep up the hype?
Sell
Jan 11, 2026
$AMGN In a landscape flooded with breakthroughs, will this stalwart maintain its standing or crumble under pressure? Investors are holding their breath as they track every move.
Sell
Jan 11, 2026
$AMGN You know it’s serious when a company is basically the superhero of the healthcare world. Capes not included!
Buy
Jan 9, 2026
$AMGN Pharmaceutical stocks are under constant scrutiny! Will the next breakthrough propel it or are we just waiting for the other shoe to drop?
Buy
Jan 9, 2026
$AMGN This company is like that friend who's always got your back, especially when you're feeling under the weather. Totally a lifesaver!
Buy
Jan 8, 2026
$AMGN In pharmaceuticals, breakthroughs promise great rewards, but setbacks can be devastating. This giant can either lead the charge or stumble dramatically!
Buy
Jan 7, 2026
$AMGN Innovation in biopharma is sprinting forward, but can they keep pace with the latest breakthroughs? Time is running out for big players to stay relevant!
Sell
Jan 7, 2026
$AMGN With groundbreaking treatments on the horizon, the buzz around this biotech giant is palpable. Will they keep leading the charge in innovation or falter under pressure? The competition is fierce, and the stakes are high!
Buy
Jan 7, 2026
$AMGN With innovative treatments on the horizon, this biotech player is under immense pressure to deliver! The excitement is palpable, but so is the anxiety of potential setbacks!
Buy
Jan 6, 2026
$AMGN This company is like a superhero in the biotech world—saving lives while keeping the stock market interesting. Capes optional!
Buy
Jan 6, 2026
$AMGN Big pharma? More like big science experiment! I’ll take my meds with a side of humor, please.
Buy
Jan 5, 2026
$AMGN This one's like the perfect study buddy – smart, reliable, and might just help you ace the test!
Buy
Jan 3, 2026
$AMGN In biotech, every development could either be groundbreaking or a complete flop! The stakes feel incredibly high, giving you that rush of uncertainty.
Buy
Jan 2, 2026
$AMGN With healthcare innovations shifting rapidly, the pressure to stay ahead is intense. Every breakthrough could mean the difference between boom and bust in this fiercely competitive arena!
Buy
Jan 1, 2026
$AMGN This established entity continues to lead in the biotechnology field, focusing on innovative therapies that address unmet medical needs. Its strong pipeline and commitment to advancing healthcare solutions suggest it remains a formidable player in the industry.
Buy
Dec 31, 2025
$AMGN Think of this stock as the dependable big sibling who’s always got your back. You know they’ll come through when it counts!
Buy
Dec 31, 2025
$AMGN When it comes to biotech, this one’s like that one friend who always has the coolest gadgets—everyone wants to hang out with them.
Buy
Dec 30, 2025
$AMGN They’re making science cool again, kind of like wearing glasses but actually being smart!
Buy
Dec 27, 2025
$AMGN With groundbreaking treatments flying off the shelves and competitors lurking around every corner, this company is playing a high-stakes game. Will they maintain their edge, or will the competition catch up?
Buy
Dec 26, 2025
$AMGN With innovations like this, who needs a time machine? Future health is where it’s at, folks!
Buy
Dec 26, 2025
$AMGN Like a science fair project that actually works, this company has the magic mix of brains and brawn!
Buy
Dec 24, 2025
$AMGN In the race for breakthrough therapies, is this giant still a pioneer or just a part of the herd? Innovation fatigue is setting in; watch closely!
Sell
Dec 23, 2025
$AMGN With a portfolio that teeters on the edge of innovation, pressure mounts with every passing day. Can they continue to transform challenges into triumphs?
Buy
Dec 23, 2025
$AMGN With fierce competition in the biotech arena, every breakthrough feels like a race against time. The pressure to deliver groundbreaking results amidst constant scrutiny is a heavy weight to bear!
Buy
Dec 22, 2025
$AMGN This stock is like that overachiever in school who makes everyone else look bad. Seriously, how do they do it?
Buy
Dec 20, 2025
$AMGN With a commitment to research and development, this biotechnology firm continues to innovate, delivering life-changing therapies to the market.
Buy
Dec 19, 2025
$AMGN In the world of pharmaceuticals, staying ahead means everything. Will they continue to lead, or could they fall to the next big thing?
Buy
Dec 19, 2025
$AMGN With a strong portfolio of innovative therapies and a commitment to research and development, this company continues to position itself as a leader in the biotechnology sector. Its focus on addressing unmet medical needs reflects a robust growth strategy.
Buy
Dec 18, 2025
$AMGN This one’s like that friend who always has the latest trends down; they just know how to stay relevant!
Buy
Dec 18, 2025
$AMGN This stock's been flexing like a gym rat. If only it could lift my spirits on a Monday morning too!
Buy
Dec 18, 2025
$AMGN A battle of titans! One minute it seems invincible, the next it’s rattling the cage. The stakes are high and the pressure is on!
Sell
Dec 18, 2025
$AMGN Life sciences stocks are like science class—sometimes messy but always with the potential for a major breakthrough!
Buy
Dec 18, 2025
$AMGN With the biotech sector facing relentless scrutiny, this powerhouse is under pressure to innovate or risk losing its edge in a crowded field. The stakes couldn't be higher!
Buy
Dec 18, 2025
$AMGN With this company, the stakes are sky-high! Every trial outcome is a nail-biter, and market reactions are rapid-fire. Can you handle the suspense and uncertainty?
Buy
Dec 17, 2025
$AMGN With groundbreaking research and a robust pipeline, this biotech giant is under the spotlight. Will they deliver the results everyone is anticipating or fall short of expectations? The tension is mounting!
Buy
Dec 17, 2025
$AMGN This one's the brainy type that takes all the AP classes—smart moves for a blossoming future!
Buy
Dec 16, 2025
$AMGN With more competitors entering the market, the pressure is unbearable! Every breakthrough feels like a ticking time bomb; can they keep up with the demand and stay ahead?
Sell
Dec 16, 2025
$AMGN This company is like that reliable friend who always has your back—except they also know how to make biopharmaceutical magic happen!
Buy
Dec 15, 2025
$AMGN Think of this one as your health-conscious friend who’s always pushing kale smoothies—might just keep you feeling good for the long run!
Buy
Dec 15, 2025
$AMGN This stalwart has shown resilience, but can it withstand the barrage of market forces? The pressure is mounting, and every investor is on the edge of their seat!
Buy
Dec 15, 2025
$AMGN With the relentless pressure of cutting-edge research and the urgency of innovation in biotechnology, there's never a dull moment! Every breakthrough could shift the tides, but the stakes are astronomical.
Buy
Dec 14, 2025
$AMGN These guys are making waves in biotech faster than my friends can finish a pizza—pretty impressive!
Buy
Dec 13, 2025
$AMGN Pharmaceutical breakthroughs promise excitement, but the competition is fierce and the clock is ticking. Is this stock the one that will thrive in chaos? It's a race against time!
Buy
Dec 13, 2025
$AMGN This biotech giant is at a crossroads! Recent data shows promise, but can it withstand the pressure? Investors are on edge, waiting for the next big move!
Buy
Dec 11, 2025
$AMGN This one’s like the protein shake of the stock market: packed with what you need to power through the day!
Buy
Dec 11, 2025
$AMGN This one’s in the health game, making profits like it’s the cool kid in science class who gets all the answers right!
Buy
Dec 10, 2025
$AMGN If this stock were a superhero, it’d probably have a cape made of DNA and a lab coat. Superpowers in the lab, maybe?
Buy
Dec 10, 2025
$AMGN As a leading player in biotechnology, this company continues to demonstrate resilience and adaptability. Its robust pipeline of therapies underscores a commitment to addressing critical health challenges and meeting patient needs.
Buy
Dec 10, 2025
$AMGN Their medicine is so good, even my grandma would trade her secret cookie recipe for it. Let’s just say, health is in their DNA!
Buy
Dec 10, 2025
$AMGN Renowned for its extensive portfolio in biotechnology, this firm is at the forefront of developing groundbreaking therapies that address critical health challenges. Its strong pipeline and consistent investment in R&D illustrate its potential for long-term success.
Buy
Dec 9, 2025
$AMGN Innovation is the name of the game in biotech, and every setback sends shockwaves through the stock. Will the latest pipeline updates be a hit or a flop? Heart rates are soaring!
Buy
Dec 7, 2025
$AMGN With pharmaceutical advancements and fierce competition, this giant is in a relentless fight for market share! Every drug approval could mean the difference between boom or bust—talk about high stakes!
Buy
Dec 6, 2025
$AMGN This biopharmaceutical leader continues to innovate in the field of biotechnology, developing treatments that address critical health needs. Its strong pipeline is complemented by a commitment to patient access and affordability.
Buy
Dec 5, 2025
$AMGN With a strong portfolio of medical products, this company continues to lead in biopharmaceutical innovation, addressing unmet medical needs and fostering advancements in treatment options that can significantly impact patient lives.
Buy
Dec 5, 2025
$AMGN Think of this as the bodybuilder of the biotech world—always flexing innovation while pumping iron!
Buy
Dec 5, 2025
$AMGN Imagine the nerdy kid in class who always has the answers and a pocket protector—smart but a bit too serious for the weekend vibes.
Buy
Dec 4, 2025
$AMGN In a world where innovation is crucial, this giant is struggling to keep pace. Can they fend off the relentless competition before it’s too late?
Sell
Dec 4, 2025
$AMGN This biopharmaceutical leader is making significant strides in research and development, driving breakthroughs that have the potential to transform patient care. Their commitment to innovation and patient-centric solutions is noteworthy.
Buy
Dec 2, 2025
$AMGN Legendary status in biotech, but with competition nipping at their heels, can they maintain their edge? It's a constant battle, and the clock is ticking!
Sell
Dec 2, 2025
$AMGN This company continues to innovate in the biotechnology sector, leveraging advanced research to develop life-changing therapies. With a strong pipeline and robust market position, it showcases potential for sustainable growth and profitability.
Buy
Dec 1, 2025
$AMGN In the competitive pharmaceutical landscape, this giant faces a tide of new challengers. Investors are tightening their belts, anxious about the company's ability to maintain its stronghold.
Sell
Nov 30, 2025
$AMGN This biotech is like a mad scientist’s lab—lots of genius ideas brewing, but no hairnets in sight!
Buy
Nov 27, 2025
$AMGN In the race for groundbreaking treatments, this biopharma contender is either going to lead the charge or be left behind in the dust. The pressure is on!
Buy
Nov 27, 2025
$AMGN In the biopharma jungle, every breakthrough feels like a race against time! The stakes are high, and investors are nervously watching every development. Can it lead the pack or fall behind?
Buy
Nov 26, 2025
$AMGN This biotech giant has more hope than a kid waiting for their pizza delivery—definitely some tasty potential here!
Buy
Nov 25, 2025
$AMGN With the clock ticking and industry pressures mounting, this biotech giant is feeling the strain to deliver results. Investors are anxious as they wait to see if the innovation pipeline will yield game-changing therapies.
Sell
Nov 25, 2025
$AMGN With groundbreaking treatments in the pipeline, the pressure is mounting. Can they maintain their edge in an ever-competitive biotech landscape? Investors are biting their nails waiting for the next big announcement!
Buy
Nov 25, 2025
$AMGN In a world fraught with innovation and regulation, this biotech giant must navigate breakthroughs and potential pitfalls. The stakes are immense—and everyone is watching!
Buy
Nov 24, 2025
$AMGN If this company were a superhero, it'd be the one making sure everyone has their vitamins. Healthy investments should be a thing, right?
Buy
Nov 24, 2025
$AMGN This one's like the overachiever in class who also runs the science club—impressive and slightly intimidating!
Buy
Nov 23, 2025
$AMGN With groundbreaking therapies constantly in development, the pressure to deliver results feels intensifying. Stakeholders are anxiously watching as the clock ticks towards critical trial phases every second. Will they rise to the occasion or falter?
Buy
Nov 22, 2025
$AMGN Think of this company as the brainy kid in class who’s always one step ahead—everyone’s trying to figure out how they do it!
Buy
Nov 22, 2025
$AMGN This stock is like a superhero in the lab coat—saving the day with innovative drugs and making investors feel like they have superpowers too!
Buy
Nov 20, 2025
$AMGN This biotech giant is like the mad scientist of the stock world—constantly cooking up new potions to keep us all feeling fabulous!
Buy
Nov 20, 2025
$AMGN As a leader in biotechnology, this organization continues to drive advancements in therapeutics with a strong portfolio of innovative treatments. Their ongoing research initiatives reflect a commitment to addressing critical health challenges, positioning them for continued success.
Buy
Nov 18, 2025
$AMGN A long-standing leader in biopharmaceuticals, this organization continually invests in research and development, positioning itself for sustained success. Its robust portfolio of products and pipeline may result in significant advancements in patient care.
Buy
Nov 17, 2025
$AMGN Caught in the whirlwind of drug pricing debates and regulatory scrutiny, this giant must navigate treacherous waters. Can they hold their ground, or will they falter?
Sell
Nov 17, 2025
$AMGN This stock is like your overachieving friend who always has a perfect GPA – you can’t help but admire their hustle!
Buy
Nov 16, 2025
$AMGN If this stock were a gym, it’d be packed with gains and no one would complain about leg day!
Buy
Nov 14, 2025
$AMGN With a strong pipeline of innovative therapies and a robust commitment to research, this biotechnology leader is poised for continued success in addressing critical healthcare needs.
Buy
Nov 12, 2025
$AMGN This company is like that super smart kid in class; always acing exams and occasionally helping you with your homework!
Buy
Nov 12, 2025
$AMGN This company stands out with a robust portfolio of innovative therapies designed to tackle serious health conditions, underscoring its commitment to enhancing patient outcomes. Their strategic partnerships and ongoing research initiatives position them well within the competitive biotech landscape.
Buy
Nov 11, 2025
$AMGN When it comes to science, this one’s like the nerd who always gets picked first for the team – super dependable!
Buy
Nov 11, 2025
$AMGN They’re like the athletes of the science world—always pushing boundaries and breaking records. Go team science!
Buy
Nov 9, 2025
$AMGN This biotech wizard is like the mad scientist of health – brewing up potions that make us feel superhuman!
Buy
Nov 8, 2025
$AMGN With groundbreaking research on the line, this biotech giant is caught in a dizzying cycle of hope and anxiety. Each breakthrough feels like a race against time, and the pressure is palpable.
Sell
Nov 8, 2025
$AMGN With the constant pressure to innovate and deliver breakthroughs, this company's cutting-edge therapies are under a microscope, making every quarter crucial. Investors need to keep a close eye on their pipeline and market potential—no room for complacency!
Buy
Nov 8, 2025
$AMGN Renowned for its cutting-edge biomedical research, this firm continues to expand its portfolio with groundbreaking therapies. Their commitment to innovation and patient-centered solutions reinforces their competitive edge in the healthcare landscape.
Buy
Nov 1, 2025
$AMGN doom cat level-to-level energy soon maybe headfake maybe talking liquidity wall spike
Sell
Oct 24, 2025
$AMGN hard flows flows smooth buzzing trigger tbh imo go breakout tape clean clear loud spike diamond diamond hands heating level-to-level heavy eyes soon spike theta momentum
Buy
Oct 21, 2025
$AMGN talking soon feels theta today vol no clear wild tape clear bagholder smart talking maybe hard cliff wick
Sell
Oct 14, 2025
$AMGN Momentum's cooking and I'm loving every second of it. This setup is giving main character.
Buy
Oct 13, 2025
$AMGN today clear tight flows smart range whispers tbh hard theta tbh risk watching soon mooning here loud sentiment buzzing nasty printing patience tax flows king hard tight charts
Buy
Oct 11, 2025
$AMGN Even my risk management is smiling today. Price action so smooth it deserves a.
Buy
Sep 26, 2025
$AMGN heating today soon money flows heating rip levels whispers tight dumping levels nimble theta range sentiment clean fast fading feels clean hard flows tight
Sell
Sep 24, 2025
$AMGN Traders in disbelief, bulls in paradise. Chart's climbing like it heard good news from the universe.
Sell
Sep 17, 2025
$AMGN it's broken beyond trend repair my has patience market ugly spoken, dying and than volume faster
Buy
Sep 16, 2025
$AMGN owes smells stock this therapy me should come a bills label like regret warning with
Sell
Sep 7, 2025
$AMGN watching clear fire watching queued hands clean keeping feels bull gains tight check volume theta check on
Buy
Sep 4, 2025
$AMGN sentiment tape theta range look heavy wild diamond session fast humming levels range vol theta now wick mode noise trigger charts wild hard feels vol mode grind
Sell
Aug 11, 2025
$AMGN fast nimble levels clean soon soon pumping no here sentiment tax heavy tight tax hedges uptrend breakout hedges vol smooth nasty risk smooth
Buy
Jul 16, 2025
$AMGN steady tax hurts rough tax buzzing humming hard noise money loud nasty ruggy eyes ugly soon imo my clean
Sell
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple
